1. Home
  2. CVKD vs CENN Comparison

CVKD vs CENN Comparison

Compare CVKD & CENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • CENN
  • Stock Information
  • Founded
  • CVKD 2022
  • CENN 2013
  • Country
  • CVKD United States
  • CENN United States
  • Employees
  • CVKD N/A
  • CENN N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • CENN Auto Manufacturing
  • Sector
  • CVKD Health Care
  • CENN Consumer Discretionary
  • Exchange
  • CVKD Nasdaq
  • CENN Nasdaq
  • Market Cap
  • CVKD 29.5M
  • CENN 30.4M
  • IPO Year
  • CVKD 2023
  • CENN N/A
  • Fundamental
  • Price
  • CVKD $12.71
  • CENN $0.68
  • Analyst Decision
  • CVKD Strong Buy
  • CENN
  • Analyst Count
  • CVKD 1
  • CENN 0
  • Target Price
  • CVKD $32.00
  • CENN N/A
  • AVG Volume (30 Days)
  • CVKD 36.2K
  • CENN 522.4K
  • Earning Date
  • CVKD 08-06-2025
  • CENN 08-12-2025
  • Dividend Yield
  • CVKD N/A
  • CENN N/A
  • EPS Growth
  • CVKD N/A
  • CENN N/A
  • EPS
  • CVKD N/A
  • CENN N/A
  • Revenue
  • CVKD N/A
  • CENN $31,097,533.00
  • Revenue This Year
  • CVKD N/A
  • CENN N/A
  • Revenue Next Year
  • CVKD N/A
  • CENN N/A
  • P/E Ratio
  • CVKD N/A
  • CENN N/A
  • Revenue Growth
  • CVKD N/A
  • CENN 234.45
  • 52 Week Low
  • CVKD $5.70
  • CENN $0.61
  • 52 Week High
  • CVKD $22.90
  • CENN $1.84
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 49.98
  • CENN 40.63
  • Support Level
  • CVKD $11.00
  • CENN $0.61
  • Resistance Level
  • CVKD $13.56
  • CENN $0.76
  • Average True Range (ATR)
  • CVKD 1.15
  • CENN 0.08
  • MACD
  • CVKD 0.25
  • CENN -0.01
  • Stochastic Oscillator
  • CVKD 80.97
  • CENN 15.29

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

About CENN Cenntro Electric Group Limited

Cenntro Inc is a designer, manufacturer, distributor, and service provider of commercial vehicles powered by either electricity or hydrogen energy sources. The company's commercial vehicles are designed to serve a variety of fleet and municipal organizations in support of city services, last-mile delivery, and other commercial applications. It has developed a series of commercial vehicle models, including Metro, Logistar, Logimax, Avantier, Teemak, and Antric One. In addition, the company has introduced an open-platform, programmable all-electric iChassis platform, designed for automated and autonomous driving. Geographically, the company generates maximum revenue from vehicle sales in the United States, and also has a presence in Europe, Asia, and other regions.

Share on Social Networks: